Table 1.
Research summaries comparing the effects of cannabinoids and placebo.
| Study ID | Study method | Human subjects | Interventional group | Control group | Follow-up (d) | Outcomes |
|---|---|---|---|---|---|---|
| Brisbois 2011 | parallel-group RCTs | advanced cancer patients | THC (2.5 mg, n = 24) | Placebo (n = 22) | 19 | Appetite, AEs, QOL |
| Johnson 2010 | parallel-group RCTs | advanced cancer patients | THC:CBD extract (2.7 mg THC and 2.5 mg CBD, n = 60), THC extract (2.7 mg THC, n = 58) | Placebo (n = 59) | 14 | Appetite, AEs, QOL |
| Strasser 2006 | parallel-group RCTs | advanced cancer patients | CE (standardized for 2.5 mg THC and 1 mg cannabidiol, n = 95) or THC (2.5 mg, n = 100) | Placebo (n = 48) | 42 | Body Weight, Appetite, AEs, QOL |